Trial Profile
A retrospective study comparing the efficacy of Transarterial chemoembolisation plus Sorafenib with Transarterial chemoembolisation monotherapy in patients with Barcelona Clinic liver cancer stage B hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 28 Feb 2017 New trial record
- 03 Feb 2017 Results published in the International Journal of Clinical Pharmacology and Therapeutics